Profil
Danielle Glenn served as the Chief Investment Officer at OrbiMed Advisors LLC.
She then worked as the Chief Financial Officer at Arctic Bioscience AS from 2020 to 2022.
Following that, she held the position of Chief Investment Officer at Bywater Capital Ltd. In 2022, she became the Chief Financial Officer & Head-Investor Relations at Zwipe AS.
Ms. Glenn completed her undergraduate degree at Harvard University.
Anciens postes connus de Danielle Glenn
| Sociétés | Poste | Fin |
|---|---|---|
| ZWIPE | Directeur Financier/CFO | 01/02/2024 |
| ARCTIC BIOSCIENCE | Directeur Financier/CFO | 31/03/2022 |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Directeur en chef des Investissements | - |
Bywater Capital Ltd. | Directeur en chef des Investissements | - |
Formation de Danielle Glenn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zwipe AS
Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards | Electronic Technology |
Arctic Bioscience AS
Arctic Bioscience AS Pharmaceuticals: MajorHealth Technology Manufactures and wholesales nutraceutical & pharmaceutical products | Health Technology |
Bywater Capital Ltd. |
















